Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-13

Clinical Trial Update: A Trial of Daily Ultraviolet Therapy to Reduce Cardiovascular Risk Factors [NA]

View source ↗

Summary

A clinical trial investigating daily ultraviolet therapy to reduce cardiovascular risk factors in hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Edinburgh | Conditions: Hypertension | NA | Status: TERMINATED